Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Japan
Biotech
AstraZeneca's heart disease trial hits, teeing up Pfizer clash
AstraZeneca reported positive top-line data from a phase 3 trial of acoramidis in Japan, teeing it up to file for regulatory approval in the country.
Nick Paul Taylor
Feb 2, 2024 6:43am
J&J’s Biosense Webster nets pulsed field ablation OK in Japan
Jan 10, 2024 10:47am
Japan greenlights Sysmex's amyloid blood test for Alzheimer's
Dec 22, 2022 10:30am
Canon doubles down on US presence with new $300M subsidiary
Nov 29, 2022 1:11pm
MEI, Kyowa confirm phase 2 cancer efficacy with fresh data drop
Nov 18, 2022 9:35am
SoftBank to bring Pear’s digital insomnia therapeutics to Japan
Mar 21, 2022 10:17am